Leukaemia inhibitory factor (LIF) production in a mouse model of spinal trauma

Neuroscience Letters

Volumn 249, Issue 1, 1998, Pages 1-4

  Kurek, John B ^a   Bennett, Tim M ^a   Bower, John J ^a   Muldoon, Catriona M ^a   Austin, Lawrence ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

N oxylamino L alanine; Leukaemia inhibitory factor; Motor neurone disease; Spinal cord

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; NEUROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; MOTOR NEURON DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RETROGRADE NERVE FIBER TRANSPORT; SCHWANN CELL; SPINAL CORD MOTONEURON; SPINE INJURY; TISSUE DISTRIBUTION; TISSUE INJURY;

AMINO ACIDS, DIAMINO; ANIMALS; BETA-ALANINE; CILIARY NEUROTROPHIC FACTOR; CYTOKINES; GROWTH INHIBITORS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LYMPHOKINES; MICE; MICE, INBRED C57BL; MOTOR NEURON DISEASE; MOTOR NEURONS; NERVE TISSUE PROTEINS; NEUROTOXINS; RECEPTORS, CYTOKINE; RECEPTORS, OSM-LIF; RNA, MESSENGER; SPINAL CORD; SPINAL DISEASES; UP-REGULATION;

EID: 0032511077     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00360-7     Document Type: Article

References (22)

1. Cheema S.S., Richards L., Murphy M., Bartlett P.F. Leukemia inhibitory factor prevents the death of axotomised sensory neurons in the dorsal root ganglion of the neonatal rat. J. Neurosci. Res. 37:1994;213-218.
2. Cheema S.S., Richards L.R., Murphy M., Bartlett P.F. Leukemia inhibitory factor rescues motorneurons from axotomy-induced cell death. NeuroReport. 5:1994;989-992.
3. Curtis R., Scherer S.S., Somogyi R., Adryan K.M., Ip N.Y., Zhu Y., Lindsay R.M., DiStefano P.S. Retrograde axonal transport of LIF is increased by peripheral nerve injury: correlation with increased expression in distal nerve. Neuron. 12:1994;191-204.
4. Gearing D.P., Gough N.M., King J.A., Hilton D.J., Simpson R.J., Nice E.C., Kelso A., Metcalf D. Molecular cloning and expression of cDNA encoding a murine myeloid leukemia inhibitory factor (LIF). EMBO J. 6:1987;3395-4002.
5. Hendry I.A., Murphy M., Hilton D.J., Nicola N.A., Bartlett P.F. Binding and retrograde transport of leukaemia inhibitory factor by the sensory nervous system. J. Neurosci. 12:1992;3427-3434.
6. Ip N.Y., McClain J., Barrezueta N.X., Aldrich T.H., Pan L., Li Y., Wiegard S.J., Friedman B., Davis S., Yancopoulos G.D. The alpha component of the CNTF receptor is required for signaling and defines potential CNTF targets in the adult and during development. Neuron. 10:1993;89-102.
7. Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell. 76:1994;253-262.
8. Kurek J.B., Austin L., Cheema S.S., Bartlett P.F., Murphy M. Up-regulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and denervated muscle. Neuromusc. Disord. 6:1996;105-114.
9. Li M., Sendtner M., Smith A. Essential function of LIF receptor in motor neurones. Nature. 378:1995;724-727.
10. Murphy M., Reid K., Hilton D.J., Bartlett P.F. Generation of sensory neurons is stimulated by leukaemia inhibitory factor. Proc. Natl. Acad. Sci. USA. 88:1991;3498-3501.
11. Murphy M., Reid K., Brown M.A., Bartlett P.F. Involvement of leukaemia inhibitory factor and nerve growth factor in the development of dorsal root ganglion neurons. Development. 117:1993;1173-1182.
12. Pennica D., Arce V., Swanson T.A., Vejsada R., Pollock R.A., Armanini M., Dudley K., Phillips H.S., Rothenthal A., Kato A.C., Henderson C.E. Cardiotrophin-1, a cytokine present in embryonic muscle, supports long term survival of spinal motorneurons. Neuron. 17:1996;63-74.
13. Ross S.M., Seelig M., Spencer P.S. Specific antagonism of excitotoxic action of 'uncommon' amino acids assayed in organotypic mouse cortical cultures. Brain Res. 14:1987;61-76.
14. Rosthtein J.D., Martin L.J., Kuncl P.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326:1992;1464-1468.
15. Rosthtein J.D., Tsai G., Kuncl P.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Staunch B.L., Coyle J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28:1990;18-25.
16. Spencer, P.S., Roy, D.N., Ludulph, A., Hugon, J., Dwivedi, M.P. and Schaumburg, H.H., Lathyrism: evidence for the role of the neuroexcitatory amino acid, BOAA, Lancet, ii (1986) 1066-1067.
17. Spencer P.S., Nunn P.B., Hugon J., Ludolph A.C., Ross S.M., Roy D.N., Robertson R.C. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 237:1987;517-522.
18. Taga T. gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J. Neurochem. 74:1996;1-12.
19. Tomida M., Yamamoto Y., Hozumi M. Three different cDNAs encoding mouse D-factor/LIF receptor. J. Biochem. 115:1994;557-562.
20. Weis J.H., Koh J., Choi D.W. Neurotoxicity of the b-N-methylamino-L-alanine (BMAA) and b-N-oxylamino-L-alanine (BOAA) on cultured cortical neurons. Brain Res. 497:1989;64-71.
21. Willis C.L., Meldrum B.S., Nunn P.B., Anderton B.H., Leigh P.N. Neuronal damage induced by b-N-oxylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7 sulfamoyl-benzo (F) quinoxaline. Brain Res. 627:1993;55-62.
22. Yamakuni H., Minami M., Satoh M. Localisation of mRNA for leukaemia inhibitory factor receptor in the adult brain. J. Neuroimmnol. 70:1996;45-53.